SCHEMBL6122234

SCHEMBL6122234

CCCC(=O)N[C@@H](CCCCOC(N)=O)C(=O)N(Cc1cccs1)Cc1cccs1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ POLB P06746 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ GAA P10253 1/20 0.39
▸ TRPM8 Q7Z2W7 3/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ CTSK P43235 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ NOD1 Q9Y239 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6121689 0.85 TSHR (0.41) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL6123149 0.82 ALDH1A1 (0.48) ALDH1A1POLBTSHRSMN1; SMN2GAA
SCHEMBL15238847 0.80 ALDH1A1 (0.51) ALDH1A1POLBTSHRSMN1; SMN2GAA
SCHEMBL17397586 0.80 ALDH1A1 (0.51) ALDH1A1POLBTSHRSMN1; SMN2GAA
SCHEMBL21114756 0.79 TSHR (0.45) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL21114755 0.79 TSHR (0.45) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL6121955 0.79 CTSK (0.48) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL6122933 0.79 CTSK (0.48) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL6121705 0.77 ALDH1A1 (0.38) ALDH1A1POLBL3MBTL1TSHRSMN1; SMN2
SCHEMBL6123293 0.76 ALDH1A1 (0.41) ALDH1A1L3MBTL1SMN1; SMN2NPC1CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640721-A2 AGONISTS THAT ENHANCE BINDING OF INTEGRIN-EXPRESSING CELLS TO INTEGRIN RECEPTORS Texas Heart Institute (US) 2013-09-25 — — EP disclosed
WO-2012068251-A2 AGONISTS THAT ENHANCE BINDING OF INTEGRIN-EXPRESSING CELLS TO INTEGRIN RECEPTORS TEXAS HEART INSTITUTE (US) 2012-05-24 — — WO disclosed
Send feedback